2026 ISPD Position Statement on tracking and reporting loss from PD therapy

Peritoneal dialysis (PD) is being promoted worldwide, but nearly half of all patients who start PD will no longer be on therapy at two years, representing an important barrier to maximizing the safe and effective use of the therapy. Loss most commonly occurs due to HD transfer, death, or the receipt of a kidney transplant, but can also occur because patients recover kidney function, transfer to another dialysis program, or are lost to follow-up. Historically, the term "technique failure" has been used to describe loss from PD, but there has been no consistent definition, and as a consequence, it has been unclear whether the observed variability in the reported risk is related to differences in patient characteristics, practice patterns, or simply differences in the way it was defined, measured, analyzed, or reported. The International Society for Peritoneal Dialysis (ISPD) convened a working group to provide recommendations around key issues related to measuring time on PD therapy. These included standardizing definitions for causes of loss, as well as their measurement, analysis, and reporting. Key performance indicators were proposed for the purpose of benchmarking and to facilitate quality improvement and research. The target audience of this document includes physicians and other healthcare providers, dialysis programs, researchers, and national registries.

Authors

Institutions

Publication Details

Journal
Peritoneal Dialysis International
Published
2026-06-17
DOI
https://doi.org/10.1177/08968608261461639
Primary Topic
Dialysis and Renal Disease Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

2026 ISPD Position Statement on tracking and reporting loss from PD therapy

Mark Lambie, Ali K. Abu‐Alfa, Mignon McCulloch, Rajnish Mehrotra et al.
Peritoneal Dialysis International
Dialysis and Renal Disease Management
article

2026 ISPD Position Statement on tracking and reporting loss from PD therapy

Mark Lambie, Ali K. Abu‐Alfa, Mignon McCulloch, Rajnish Mehrotra, David Wayne Johnson, Olof Heimbürger, Angela Yee‐Moon Wang, Robert R. Quinn, Arpana Iyengar, Annabel Boyer, Annie‐Claire Nadeau‐Fredette, Danielle E. Fox, Patricia Gooden, Simon Davies, Thyago Proença de Moraes, Jeffrey Perl, Nancy Verdin
article en

Abstract

Peritoneal dialysis (PD) is being promoted worldwide, but nearly half of all patients who start PD will no longer be on therapy at two years, representing an important barrier to maximizing the safe and effective use of the therapy. Loss most commonly occurs due to HD transfer, death, or the receipt of a kidney transplant, but can also occur because patients recover kidney function, transfer to another dialysis program, or are lost to follow-up. Historically, the term "technique failure" has been used to describe loss from PD, but there has been no consistent definition, and as a consequence, it has been unclear whether the observed variability in the reported risk is related to differences in patient characteristics, practice patterns, or simply differences in the way it was defined, measured, analyzed, or reported. The International Society for Peritoneal Dialysis (ISPD) convened a working group to provide recommendations around key issues related to measuring time on PD therapy. These included standardizing definitions for causes of loss, as well as their measurement, analysis, and reporting. Key performance indicators were proposed for the purpose of benchmarking and to facilitate quality improvement and research. The target audience of this document includes physicians and other healthcare providers, dialysis programs, researchers, and national registries.

Peritoneal Dialysis International
St. Michael's Hospital (CA), Karolinska University Hospital (SE), University of Cape Town (ZA), National University of Singapore (SG), University of Calgary (CA), Royal Free London NHS Foundation Trust (GB), Pontifícia Universidade Católica do Paraná (BR), University of Washington (US), The Royal Free Hospital (GB), Karolinska Institutet (SE), Yale University (US), Kidney Care UK (GB), Centre Hospitalier Universitaire de Caen Normandie (FR), St. John's National Academy of Health Sciences (IN), University College London (GB), Keele University (GB), Université de Montréal (CA), American University of Beirut (LB), Université de Caen Normandie (FR)
Openalex Percentile: Top 7%
Dialysis and Renal Disease Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.